Cryoinjury of MCF-7 human breast cancer cells and its enhancement using tumor necrosis factor-alpha (TNF-α) as an adjuvant, were investigated. Through a series of experiments in a two level factorial design critical parameters affecting cryotherapy responses were identified. The cryoinjury was investigated by quantifying the effects of four freeze/thaw (F/T) parameters, selected to be within the expected range for a cryosurgical iceball. Thermal parameters considered were cooling rate (5 and 50 ºC/min), end temperature (-20 and -80 ºC), hold time (0 and 10 min), and thawing rate (20 and 100 ºC/min). After exposing the cells to the selected F/T conditions, survival was assessed and statistically analyzed to determine the effect of each parameter and their interactions. A statistical analysis shows that the end temperature and hold time were the two most significant parameters in the range studied. This suggests that proper control of these two parameters is important to achieve desired cryodestruction of MCF-7 cells. Enhancement of cryoinjury by TNF-α was also investigated in a tissue equivalent cryoinjury model in which a cryosurgical iceball is formed. MCF-7 cells cultured in a collagen matrix underwent a controlled F/T with or without TNF-α pre-treatment at 100 ng/ml for 24 hours. Post-thaw viability of MCF-7 cells was assessed at three hours, and at one and three days after freezing. Although the TNF-α treatment alone induced neither apoptotic nor necrotic cell death, the combination of TNF-α pre-treatment and freezing enhanced the immediate cryoinjury of MCF-7 cells, and significantly impaired the post-thaw recovery. Without TNF-α treatment, MCF-7 cell cultures were repopulated, reaching approximately 80% survival at day 3 even after severe cryoinjury (≤ 20% survival) at three hours. In contrast, this repopulation was significantly inhibited by TNF-α pre-treatment, in which case the viability of the frozen region remained below 40% at day 3. The effects of TNF-α on the cryoinjury of MCF-7 cells suggest that TNF-α may serve as a potent adjuvant to cryosurgery of breast cancer.
Introduction
As breast cancer diagnostic technologies advance, the detection limit for breast tumors has become small enough to be treated without radical mastectomy. Thus, there is a growing interest in the use of minimally invasive surgical techniques for treating small breast tumors (1, 2) . Many of these techniques are thermal therapies using localized freezing or heating to destroy malignant tissues. Among these minimally invasive thermal surgeries, cryosurgery has an advantage over other hyperthermic techniques including the availability of various intraoperative monitoring techniques such as ultrasound, CT, MRI, and electric impedance methods (3). Moreover, recent clinical studies (4-7) have illustrated the effectiveness of cryosurgery in treating small breast tumors, especially smaller than 2 Technology in Cancer Research & Treatment, Volume 6, Number 6, December 2007 cm. However, a significant challenge is posed by the risk of incomplete tumor destruction at the periphery of the iceball, where tumor tissue is exposed to mild freezing/thawing (F/T) conditions. Since the incomplete destruction may increase the risk of tumor recurrence, cryosurgery is currently performed with a surgical margin (1, 8) . The surgical margin, however, cannot completely remove the risk of tumor recurrence, and may result in undesirable normal tissue damage due to over-freezing. Therefore, information on the extent of cryoinjury at given F/T conditions and clinically feasible strategies to augment the cryoinjury at mild F/T conditions are in demand. These strategies can also improve intraoperative image guidance by enabling more precise matching of the cryolesion with the edge of the iceball, which is usually monitored during the surgical procedure.
The local minimum temperature during the surgical procedure, i.e., end temperature (ET), has been used in clinical settings as a primary measure of the extent of cryoinjury (9, 10). However, the extent of cryoinjury is also affected by other F/T parameters of cryosurgical protocols including cooling rate (CR), hold time (HT), thawing rate (TR), and number of freezing cycles. Effects of these F/T parameters have been studied in several tumors including prostate (11) and uterine fibroids (12), but the understanding of the effects on breast cancer is still limited. Thus, the cryoinjury due to the individual and combined effects of these parameters is still in need of investigation. Previous work on the cryoinjury of breast cancer cells and tissues include those by Hong and Rubinsky (13) , who studied ice morphology within frozen normal and malignant breast tissues. Rui et al. (14) investigated the effects of the ET on damage to three different human breast cancer cell lines (MCF-7, MDA-468, and HBL-100). Rabin et al. (8) performed long-term follow-up study of cryosurgery using a sheep breast model (normal tissue). In spite of these studies, more systematic studies are still warranted to elucidate and quantify the effects of other F/T parameters and their interactions, the possibility to enhance the cryodestruction.
Even with a quantitative understanding of the F/T conditions guaranteeing cryodestruction, it is still challenging to achieve complete tumor destruction without surrounding normal tissue damage. It is primarily due to mild F/T conditions at the periphery of the iceball. Thus, it is highly desired to make tumor cells and tissue more susceptible to cryoinjury. To enhance cryoinjury under mild F/T conditions, several different types of adjuvants have been proposed and tested. Ikekawa et al. (15) tested two chemotherapeutic agents, peplomycin and adriamycin. They reported the improvement of treatment outcome due to increased uptake of peplomycin when it was administrated after cryosurgery. Clarke et al. (16) showed augmented cryoinjury of PC-3 human prostate cancer cells using 5-fluorouracil. More recently, Mir and Rubinsky (17) tested bleomycin as an adjuvant for breast cancer, and reported significantly increased cellular cryoinjury at low concentration of bleomycin. Adjuvants manipulating freezing-induced biophysical phenomena have also been investigated. The feasibility of using anti-freeze proteins, which could augment cryoinjury by changing the crystalline structure of ice into a spear-like shape at the margin of the cryolesion, as cryoadjuvants were demonstrated in (18, 19) . In other studies, the cryoinjury of AT-1 prostate and MCF-7 breast cancer cells could be augmented by inducing a secondary solidification (i.e., eutectic solidification) within the edge of the cryolesion (20, 21) . In addition to these mechanisms of direct cell injury, cryodestruction of microvasculature could also be accentuated by use of . In that study, a small amount of pre-administrated TNF-α could drastically enlarge the extent of vascular stasis three days after cryosurgery. However, the effects of TNF-α on the direct cell injury were not studied.
In the present study, the cryoinjury of MCF-7 human breast cancer cells was studied to quantify the effects of four F/T parameters on the cryoinjury through a series of experiments by a two-level factorial design. These parameters were CR, ET, HT, and TR. After exposing the cells to F/T conditions determined by the factorial design, survival was assessed and statistically analyzed to determine the effect of each parameter and their 2-way interaction. In addition to characterizing the cryoinjury, the effects of TNF-α on the cryoinjury and the recovery of MCF-7 cells were studied using a tissue equivalent cryoinjury model. MCF-7 cells cultured in a collagen matrix underwent a simulated cryosurgery with or without TNF-α pre-treatment. Post-thaw viability of MCF-7 cells at several time points was assessed to quantify direct cell injury and cell-based recovery in this tissue-like environment. The results of the present study provide baseline data to estimate the extent of the cryoinjury of breast cancer cells with respect to various F/T conditions. The work also helps to understand the effect of the adjuvant TNF-α on the cryoinjury and post-thaw recovery of breast cancer cells. Ultimately, the results from the present study may help to optimize cryosurgical protocols for improved surgical outcomes with a more clearly defined cryolesion and lower recurrence rates.
Materials and Methods

MCF-7 Cell and 3-D Tissue Equivalent Constructs
A human breast cancer cell line (MCF-7) was obtained from American Type Culture Collection (ATCC) and maintained in culture medium (D-MEM/F12, Life Technologies, Grand Island, NY) supplemented with 5% fetal bovine serum, 1% penicillin/streptomycin, and 0.01mg/ml of insulin. The cells were incubated in 75 cm 2 T-flasks at 37 ºC and 5% CO 2 environment. Cultured MCF-7 cells were separated from the culture flask by immersion in 0.05% trypsin and 0.53 mM EDTA, then suspended in culture medium such that the fi-nal trypsin concentration was < 0.005%. The cells were consistently collected when 60 ~ 80% confluent and in log phase growth. After separation, the cells were pelleted by centrifugation and the excess medium was removed. For cell suspension experiments, the cell pellet was re-suspended in isotonic phosphate-buffered saline (PBS) at a nominal cell concentration of 2 × 10 6 cells/ml. In order to construct tissue equivalents (TEs), the collected MCF-7 cells were mixed in type I collagen (Organogenesis, Canton, MA) at a concentration of 1 × 10 5 cells/ml. The detailed composition of TEs was previously described (23). Approximately 3 ml of the collagen and cell mixture was cast in a petri dish and polymerized at 37 ºC for one hour. After polymerization, the TEs were incubated at 37 ºC in 3ml of culture medium.
Design of Experiment I -Parametric Analysis of Cryoinjury of MCF-7 Cells
To identify the significance of F/T parameters in the cryoinjury of MCF-7 tumor cells, a two-level factorial design was employed. The application of this methodology to other tumor systems has been described elsewhere (11). Briefly, four F/T parameters were chosen for the study -CR, ET, HT, and TR. Within the relevant range for the cryosurgery protocol, maximum and minimum values of each parameter were determined as summarized in Table I . Using these values, a parametric domain was constructed, and the midpoint was determined with the averaged values of each parameter. A typical F/T protocol was generated by a combination of these four parameters as shown in Figure 1 . The viability of MCF-7 cells was assessed after each F/T condition (n = 3 for each F/T condition) and the data were statistically analyzed to quantify the significance of individual F/T parameters as well as interactions between any two parameters.
To precisely generate various F/T conditions, a thermally controlled microscope stage (BCS196, Linkam Scientific Instruments, Surrey, UK) was used. Approximately 20 μl of MCF-7 cell suspensions were placed on the stage and experienced pre-programmed F/T conditions generated by the factorial design. After the experiments (n = 3 for each parametric point), the viability of MCF-7 cell suspensions was immediately measured by a membrane integrity assay. Approximately 10 μl of the sample was collected after F/T, and incubated with 9 μM Hoechst (H-33342, Molecular probes, Eugene, OR) and 16 μM propidium iodide (P-1304, Molecular probes, Eugene, OR) for 15 minutes at 37 ºC. After incubation, viability was assessed under a fluorescent microscope (BX-50, Olympus, Melville, NY) by counting more than 200 cells for each sample. All viability values were normalized against the control viability, which was always higher than 90%.
Design of Experiment II -Effects of TNF-α on Cryoinjury and Post-thaw Recovery of MCF-7 Cells in Tissue Equivalents
The TEs were prepared in four different groups (n=3 for each) -control, freeze/thaw only, TNF-α treatment only, and TNF-α treatment with F/T. After two days culture in matrix medium, the two TNF-α treatment groups (TNF-α treatment only and TNF-α treatment with F/T) were treated with TNFα at 100 ng/ml for 24 hours at 37 ºC. Then, the groups of freeze/thaw only and TNF-α treatment with F/T underwent axisymmetric F/T imitating in vivo cryosurgery using a jig as shown in Figure 2A . The jig guided a 3mm diameter argon-driven cryosurgical probe (CRYOprobe CRYO-40, Endocare, Irvine, CA) in the center of the TE. A detailed description of the setup is provided in (23). Briefly, this setup created controlled axisymmetric F/T and monitored the local temperature of the TEs using four T-type thermocouples (5TC-TT-T-36, Omega, Stamford, CT) located at 6, 11, 16, and 21 mm from the center of the probe. During the F/T protocol, the probe temperature was maintained at -80 ºC for 10 minutes, after which the TEs were passively thawed at room temperature. The bottom of the petri dish was insulated with a Styrofoam block to minimize the heat loss. The local end temperature during the F/T cycle is presented in Figure 2B . At the end of freezing, the edge of the iceball extended approximately 15 mm from the probe. After F/T, each TE tissue was covered with 3 ml of culture medium and placed in an incubator until injury assessment.
Both the viability and the population density of MCF-7 cells were assessed by the membrane integrity assay to quantify the effect of TNF-α on cell proliferation, cryoinjury, and post-thaw recovery (n = 3 for each group). For the assay, TE samples were incubated in culture media with 9 μM Hoechst and 16 μM ethidium homodimer for 30 minutes at 37 ºC and washed in HBSS. After incubation, the numbers of viable and total cells were counted under a fluorescent microscope.
The cells were counted at 0, 6, 11, and 16 mm away from the cryoprobe, and at least four different fields at each radial location were examined. This assay was performed at three different time points after freezing (three hours, one and three days referred to as day 0, day 1, and day 3, respectively). The local viability was evaluated as described below,
The viability defined in Equation [1] is a relevant measure of both cell survival and population density, and can be higher than 100% if the number of live cells is more than that of the control due to cell proliferation and/or migration (23). In addition, the number of the cells per microscopic field was also used as a measure of the cell population density.
Statistical Analysis
The significance of each F/T parameter was determined as described in (11, 12) . Briefly, after the assessment of postthaw viability, the significance of each parameter, which is called "Effect", was determined as
where N is the number of parameters, i.e., 4 for present study. The effect implies the averaged change of the viability with respect to the given parameter. Minimum significance factor, μ E , was statistically estimated to gauge the variation due to experimental uncertainty.
where "t" is the t-statistic for a given confidence level (99% for the present study) from the Student's t-distribution (i.e., t = 2.72), "s" is the pooled standard deviation of all experiments, "m" is the number of parameter levels raised to the number of parameters minus one (i.e., m = 2 4-1 = 8), and "k" is the number of separated trials at each condition (i.e., k = 3 for the present study). Similar to the effect of a single parameter, the effects of interaction between two parameters, and the minimum significance factor, μ I , were also estimated. To quantify the nonlinearity of the relation between viability and thermal conditions, a curvature was calculated as follows,
[Curvature] = (Averaged Viability of All Points) -(Viability of Midpoint) [4] According to this definition, positive curvature implies that the viability of the midpoint is smaller than the linearly interpolated viability from the viability of all points (i.e., more cryodestruction at the midpoint than the linear estimation).
The minimum significance of curvature due to experimental uncertainty, μ C , was also estimated as below where "c" is the number of runs at the mid point (i.e., c = 3).
Results
Cryoinjury of MCF-7 Cells in the Parameteric Domain
The parametric domain and corresponding post-thaw viability of MCF-7 cells are shown in Figure 3 . Without a hold time (HT = 0 min), a significant decrease in viability was observed along the end temperature axis, but the change with respect to the other parameters was less significant. Regardless of the other parameters, the viability with ET = -80 ºC was lower than 10% (i.e., 7.8 ± 2.7%, 4.5 ± 1.9%, 5.6 ± 3.7%, and 6.8 ± 1.8%). At HT = 10 min, the viability generally decreased at all F/T conditions. However, a significant decrease in viability was still noted with respect to ET, and the viability was again lower than 10% when ET = -80 ºC (i.e., 3.4 ± 2.1%, 6.5 ± 3.7%, 3.5 ± 2.9%, and 3.7 ± 0.6%). Interestingly, the viability of the mid-point (CR = 27.5 ºC/min, ET = -50 ºC, HT= 5 min, and TR = 60 ºC/min) was 6.2 ± 1.9% and very close to the minimum viability within the parametric domain studied.
Effects of Freeze/Thaw Parameters on Cryoinjury of MCF-7 Cells
To quantify the significance of each parameter within the range studied, a statistical analysis was performed and the results are summarized in Table II . The analysis indicates that the ET was the most significant parameter affecting the post-thaw viability of MCF-7 cells (Effect = 40.2), and the HT was the second most significant parameter (Effect = -16.3). A positive effect means the viability increases with the parameter increase, and a negative one means the viability decreases. The effect of CR (= -5.9) was smaller than the effects of ET and HT, and that of TR (= 3.5) was comparable to the minimum effect value for statistical significance (μ E = 3.2). Among the interaction of the parameters, the interaction of ET and HT is the most significant (Effect = -15.5). The effects of other interactions were either similar to or smaller than the statistically significant minimum effect value (μ I = 3.2). Although the interactions among three parameters were also analyzed, the effects were smaller than ET-HT interactions (data are not shown). The curvature in viability (= 19.7), which was significantly larger than μ C (= 6.6), suggests strong non-linear dependence of the viability on F/T conditions. This non-linearity indicates that the viability at the mid-point condition was significantly below the mean value estimated from the linear interpolation of all other points.
Cryoinjury of MCF-7 Cells in TE Constructs
The post-thaw viability of MCF-7 cells in TE constructs are shown in Figure 4 . At day 0, when the viability was a measure of immediate cellular injury, significant cell death was observed throughout the frozen region (i.e., radial location ≤ 15 mm). The extent of the injury was slightly lessened radially such that the viability increased from 0.3 ± 0.5% at 0 mm to 19.3 ± 15.1% at 11 mm. These viabilities were sig- nificantly lower than the viability of MCF-7 cell suspensions after similar freezing conditions shown in Figure 4 . This confirmed that the cryoinjury estimation using cells in suspension is more conservative than cells in a tissue-like environment (12, 25) . In the unfrozen region, however, viability was dramatically higher (96.2 ± 5.6%), which was similar to control. This shows that mild hypothermic temperatures at 16mm (ET = 2.8 ± 0.2 ºC, Figure 3B ) had minimal effect on the survival of MCF-7 cells.
At day 1, the most distinct change in cell viability was noted at 11mm where viability increased from 19.3 ± 15.1% at day 0 to 76.8 ± 8.1%; thus, showing a dramatic recovery of cell viability during 24 hours post-cryoinjury. Since the higher viability at the later time points (day 1 and 3) reflected cell proliferation and possible migration, this increase could be a measure of cellular recovery after cryoinjury. At 0 and 6 mm where the cells were most severely injured, viability also increased but the magnitude of the increase was significantly less (15.9 ± 10.5% at 0mm and 15.8 ± 4.6% at 11mm). At day 3, this cellular recovery trend propagated radially inward so that significantly increased viability was observed at 6 mm to 52.1 ± 49.4% from 15.8 ± 4.6% at day 1.
Effects of TNF-α on MCF-7 Cells in TE Constructs
The average cell number per field, a measure of MCF-7 cell density in TEs, and the corresponding percent viability of MCF-7 cells are summarized in Table III . The cell density of TNF-α treated TEs was higher than control at all three time points. Although the largest difference was observed at day 0 (i.e., 24 hours after the TNF-α treatment), the difference was not statistically significant (p > 0.05). Regardless of the TNF-α treatment, more than 90% of MCF-7 cells in TEs were viable. The viability of TNF-α treated TEs was slightly lower than the control, but it was also not statistically significant (p > 0.05).
The effects of the TNF-α dose used in the present study on MCF-7 cells were further investigated by morphological observation as shown in Figure 5 . Figure 5 shows fluorescence micrographs of MCF-7 cells after TNF-α treatment, with negative and positive controls for apoptosis. The positive control ( Figure 5C ) was treated with paclitaxel (0.1 μg/ml for 24 hrs) to induce apoptosis, while negative control (Figure 5A) was cultured in medium alone. While the paclitaxel treated MCF-7 cells clearly showed apoptosis associated morphological change including nuclear chromatin condensation, the TNF-α treated MCF-7 cells looked similar to the negative control, and did not have any notable morphological change. These results demonstrate that the present dosage and duration of the TNF-α treatment alone has minimal effects on the viability of MCF-7 cells.
Effects of TNF-α on the Cryoinjury and Recovery of MCF-7 Cells in TE Constructs
The post-thaw viabilities of TNF-α treated MCF-7 cells in TE constructs are shown in Figure 6 . Based on the viability at day 0, the immediate cryoinjury of MCF-7 cells was en- If an effect is smaller than these values, the effect of that parameter is not statistically significant.
Figure 4:
Post-thaw viability of MCF-7 cells in TEs without TNF-α treatment. The MCF-7 cells throughout the frozen region was significantly injured, but much of the region was repopulated with viable MCF-7 cells at later time points.
hanced in the frozen region. No viable cells were observed at 0 or 6 mm, and the viability at 11mm was lower than that at the same location without TNF-α treatment (10.2 ± 12.5% with TNF-α treatment, but 19.3 ± 15.1% without TNF-α treatment). Since the TEs were frozen and thawed using an identical protocol, the difference in viability should be due to the TNF-α pre-treatment. However, the viability of the unfrozen region noticeably increased due to the TNF-α treatment (i.e., 112.6 ± 32.5%). This result is different from what was observed after TNF-α treatment alone (Table III) . This indicates that combination of mild hypothermic temperature and TNF-α treatment may stimulate MCF-7 cell proliferation, which if these cells include residual tumor cells could result in adverse treatment outcome.
The effects of TNF-α treatment on the cellular recovery after cryoinjury were evaluated by comparing viability at the later time points. At day 1, the recovery (i.e., repopulation) of MCF-7 cells in the frozen region was significantly reduced compared to the F/T only group (p<0.05). The viability at 11 mm only recovered to 37.8 ± 20.0%, compared to a viability of 76.8 ± 8.1% without TNF-α treatment. Moreover, no viable cells were observed at 0 and 6 mm. The unfrozen region showed higher viability (116.4 ± 34.7%) than the control. The suppressed recovery continued at day 3, when the viability at 11 mm remained at 46.5 ± 22.4%, with no viable cells observed at 0 and 6 mm. The viability of the cells in the unfrozen region decreased to 98.0 ± 10.3% as well, but it is not statistically significant. These results suggest that TNF-α was very effective at enhancing the cryoinjury and inhibiting the repopulation of MCF-7 cells after cryosurgery.
Discussion
This study investigated factors, both physical and biological, that affect cryotherapeutic destruction of tumor cells, in an effort to determine optimal conditions for tumor destruction with minimal damage to surrounding normal tissue. First, evaluation of the relative importance of four physical parameters of treatment (HT, ET, CR, and TR) indicated that HT and ET are the most crucial variables within clinical cryosurgical parameters. Second, the role of TNF-α as an exogenous adjuvant was examined, and found to produce enhanced tumor destruction and to reduce tumor cell recovery, which together may reduce recurrence. Further studies will be needed to optimize the combination of physical parameters of cryotherapy and biologic pretreatment of the target tissue.
Significance of F/T Parameters on Cryoinjury of MCF-7 Cells
The maximum and minimum values of each parameter studied are in a range relevant for determining the relative significance of F/T parameters in cryosurgical protocols. Cells and tissues during cryosurgery undergo substantial variations of cooling rates, end temperatures, hold times, and thawing rates. Cooling rates typically vary from 100 ºC/min near the surgical probe to 1 ~ 5 ºC/min at the periphery of the iceball (25). Although the lethal temperature of tissue destruction is considered to be somewhere between -40 to -60 ºC, end temperatures range from 0 ºC at the iceball edge to the probe temperatures (9, 10). In vivo thawing rates depend on the thawing scheme, but they are expected to be slightly higher than cool- ing rates due to blood perfusion and metabolic heat generation. Thus, the parameteric domain studied was relevant to investigate the cryoinjury of MCF-7 cells within iceball.
The present result suggests that other F/T parameters besides ET and their interactions influence the extent of cryoinjury and should be considered to design cryosurgical protocols. Moreover, the curvature in viability implies that the cryoinjury correlated in a highly nonlinear manner with the F/T parameters. However, in order to apply the present results to in vivo cryosurgery, other injury mechanisms, which play important roles in vivo such as vascular injury (24), should be carefully considered when extrapolating the present results of direct cell injury. In addition to other injury mechanisms, wound healing and/or regrowth of diseased tissues after cryosurgery should be carefully considered (26, 27) .
Efficacy of TNF-α as a Cryoadjuvant
The present study shows that the combination of TNF-α and freezing can enhance post thaw injury of MCF-7 cell. Two distinct effects are noted with this cryoadjuvant: i) enhanced immediate cell destruction where mild freezing conditions were imposed, and ii) reduction in local tumor regrowth (i.e., disease recurrence) for several days post-freeze/thaw. Thus, TNF-α can be a potent adjuvant to cryosurgery, although the underlying interaction mechanism of freezing and TNFα requires further study. Moreover, these synergistic effects can be maximized without the toxicity associated with high dose of TNF-α by delivering TNF-α directly to tumor using gold nanoparticles (28, 29) local injection. Another merit of TNF-α as a cryoadjuvant is it can also enhance tumor vascular destruction as reported in (22, 29) . Thus, when TNF-α is used in cryosurgical treatment, both malignant cells and vasculature can be targeted simultaneously. Further re-search on the dosage and timing of TNF-α administration is still required to maximize these benefits. Finally, the cell proliferation in the presence of TNF-α and mild hypothermia (See Figure 6) , should be fully investigated to minimize the possibility of potential adverse treatment outcome such as stimulating malignant cell growth.
Summary
Cryoinjury of MCF-7 human breast cancer cells and its enhancement using a molecular adjuvant were investigated in vitro. The cryoinjury of MCF-7 cells was investigated by quantifying the effects of four freezing/thawing (F/T) parameters through a series of experiments by a two-level factorial design considering CR, ET, HT, and TR. In addition, the efficacy of TNF-α as cryosurgical adjuvant was tested in tissue equivalent cryoinjury model of MCF-7 by comparing the extent of cryoinjury and post-thaw viability after a simulated cryosurgical procedure with and without TNF-α pre-treatment. The conclusions are summarized as follows:
I. ET and HT were the two most significant parameters within the range studied, and proper control of these two parameters can achieve synergistic cryodestruction of MCF-7 cells within the parametric domain studied.
II. Although the TNF-α treatment alone at the presently studied dosage and duration induced neither apoptotic nor necrotic cell death, the combination of TNF-α pre-treatment and freezing enhanced the immediate injury and significantly impaired the post-thaw recovery.
III. Combination of mild hypothermia and TNF-α treatment may stimulate MCF-7 cell proliferation and further research is warranted to investigate this potential adverse outcome.
